Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
Katherine Marotte
Advertisement
Katherine Marotte is principal scientist, viral safety testing services department, at Eurofins Lancaster Laboratories. She has 14 years of virology experience and specializes in assay development and GMP viral testing.
Articles by Katherine Marotte
Advertisement
Latest Updated Articles
Unprocessed Bulk Testing for BiopharmaceuticalsPublished: December 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
